Identification of pre-treatment HBV DNA markers that are predictive of response to lamivudine therapy in patients infected with HBV precore variants.

被引：0
|
作者：
Korba, B
Smedile, A
Rizzetto, M
Lagget, M
Gerin, J
Ciancio, A
机构：
[1] Georgetown Univ, Rockville, MD USA
[2] Osped San Giovanni Battista, Dept Gastroenterol, Turin, Italy
来源：
ANTIVIRAL RESEARCH | 2003年 / 57卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
11
引用
下载
收藏
页码：A43 / A43
页数：1
相关论文
共 50 条
  • [31] Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy
    Calisti, Giorgio
    Muhindo, Rose
    Boum, Yap, II
    Wilson, Laurence A.
    Foster, Geraldine M.
    Geretti, Anna Maria
    Bhagani, Sanjay
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2015, 109 (11) : 723 - 729
  • [32] Detection and identification of HBV DNA YMDD motif mutation during lamivudine treatment using oligonucleotide array
    赵伟
    刘伟
    刘全俊
    张林
    张汉荣
    刘新珏
    周镇先
    中华肝脏病杂志, 2003, (03) : 51 - 52
  • [33] Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naive Chronic HBV-Infected Patients
    Liao, Hao
    Li, Le
    Zheng, Wei V.
    Zou, Jun
    Yu, Guangxin
    Si, Lanlan
    Ge, Feilin
    Zhou, Tao
    Ji, Dong
    Chen, Xiangmei
    Xu, Dongping
    Cheng, Guanxun
    Liu, Yan
    Chen, Junhui
    DISEASE MARKERS, 2022, 2022
  • [34] HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance
    Shin, Jung Woo
    Jung, Seok Won
    Park, Bo Ryung
    Kim, Chang Jae
    Eum, Jun Bum
    Kim, Byung Gyu
    Jeong, In Du
    Bang, Sung-Jo
    Park, Neung Hwa
    ANTIVIRAL THERAPY, 2012, 17 (02) : 387 - 394
  • [35] Quantitative HBV-DNA testing as an early predictor of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B
    Buti, M
    Sánchez-Avila, JF
    Cotrina, M
    Jardi, R
    Rodríguez-Frías, F
    Costa, X
    Esteban, R
    Guardia, J
    JOURNAL OF HEPATOLOGY, 2001, 34 : 161 - 161
  • [36] Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand
    Khamduang, Woottichai
    Gaudy-Graffin, Catherine
    Ngo-Giang-Huong, Nicole
    Jourdain, Gonzague
    Moreau, Alain
    Luekamlung, Nuananong
    Halue, Guttiga
    Buranawanitchakorn, Yuwadee
    Kunkongkapan, Sura
    Buranabanjasatean, Sudanee
    Lallemant, Marc
    Sirirungsi, Wasna
    Goudeau, Alain
    PLOS ONE, 2012, 7 (07):
  • [37] Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients
    Deal, C
    Ajana, F
    Canva, V
    Mouton, Y
    Yazdanpanah, Y
    Wattré, P
    Bocket, L
    ANNALES DE BIOLOGIE CLINIQUE, 2002, 60 (05) : 581 - 588
  • [38] High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China
    Jia, Hui-Hua
    Li, Kai-Wen
    Chen, Qin-Yan
    Wang, Xue-Yan
    Harrison, Tim J.
    Liang, Shu-Jia
    Yang, Qing-Li
    Wang, Chao
    Hu, Li-Ping
    Ren, Chuang-Chuang
    Fang, Zhong-Liao
    INTERVIROLOGY, 2018, 61 (03) : 123 - 132
  • [39] Predictive Value of Pre-treatment Amygdala Volume for Electroconvulsive Therapy Response in Severely Depressed Patients
    ten Doesschate, Freek
    van Wingen, Guido A.
    van Waarde, Jeroen A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 119S - 120S
  • [40] Addition of adefovir dipivoxil to lamivudine therapy results in a significant reduction in HBV DNA and serum ALT in compensated chronic hepatitis B patients with YMDD variant HBV and a reduced response to lamivudine-52 week results
    Schiff, E
    Willems, B
    Leung, N
    Lau, G
    Trepo, C
    Wright, T
    Watkins, K
    Woessner, M
    Brosgart, C
    Bourne, E
    Tait, D
    HEPATOLOGY, 2002, 36 (04) : 636A - 636A
12345